Literature DB >> 20497602

Schizophrenic: forever young?

Benedetta Frida Baldi1, Christine Hoyer, Nicolas Le Novère.   

Abstract

Schizophrenia is a multifactorial complex disease with a large impact on society. Many hypotheses have been proposed over the years to explain its causes, and genomics and functional genomic approaches may shed light on the reason behind these controversies and discrepancies. We give an overview of several approaches that have been used to identify the genetic causes and molecular phenotypes of the disease. We focus on a recent microarray analysis by Torkamani and colleagues on the evolution of regulatory networks in normal and schizophrenic brains. Combining the conclusion of that study with the prevalent hypotheses of schizophrenia, we suggest that the schizophrenic brain might resemble a juvenile brain.

Entities:  

Year:  2010        PMID: 20497602      PMCID: PMC2887076          DOI: 10.1186/gm153

Source DB:  PubMed          Journal:  Genome Med        ISSN: 1756-994X            Impact factor:   11.117


  25 in total

Review 1.  NMDA receptor hypofunction model of schizophrenia.

Authors:  J W Olney; J W Newcomer; N B Farber
Journal:  J Psychiatr Res       Date:  1999 Nov-Dec       Impact factor: 4.791

Review 2.  Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysis.

Authors:  Christine Konradi
Journal:  Brain Res Brain Res Rev       Date:  2005-06-20

3.  A highly significant association between a COMT haplotype and schizophrenia.

Authors:  Sagiv Shifman; Michal Bronstein; Meira Sternfeld; Anne Pisanté-Shalom; Efrat Lev-Lehman; Avraham Weizman; Ilya Reznik; Baruch Spivak; Nimrod Grisaru; Leon Karp; Richard Schiffer; Moshe Kotler; Rael D Strous; Marnina Swartz-Vanetik; Haim Y Knobler; Eilat Shinar; Jacques S Beckmann; Benjamin Yakir; Neil Risch; Naomi B Zak; Ariel Darvasi
Journal:  Am J Hum Genet       Date:  2002-10-25       Impact factor: 11.025

4.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies.

Authors:  Patrick F Sullivan; Kenneth S Kendler; Michael C Neale
Journal:  Arch Gen Psychiatry       Date:  2003-12

Review 5.  Recent advances in the phencyclidine model of schizophrenia.

Authors:  D C Javitt; S R Zukin
Journal:  Am J Psychiatry       Date:  1991-10       Impact factor: 18.112

6.  Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress.

Authors:  S Prabakaran; J E Swatton; M M Ryan; S J Huffaker; J T-J Huang; J L Griffin; M Wayland; T Freeman; F Dudbridge; K S Lilley; N A Karp; S Hester; D Tkachev; M L Mimmack; R H Yolken; M J Webster; E F Torrey; S Bahn
Journal:  Mol Psychiatry       Date:  2004-07       Impact factor: 15.992

7.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

Authors:  J H Krystal; L P Karper; J P Seibyl; G K Freeman; R Delaney; J D Bremner; G R Heninger; M B Bowers; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1994-03

Review 8.  Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature.

Authors:  Elliot M Goldner; Lorena Hsu; Paul Waraich; Julian M Somers
Journal:  Can J Psychiatry       Date:  2002-11       Impact factor: 4.356

9.  ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context.

Authors:  Adam A Margolin; Ilya Nemenman; Katia Basso; Chris Wiggins; Gustavo Stolovitzky; Riccardo Dalla Favera; Andrea Califano
Journal:  BMC Bioinformatics       Date:  2006-03-20       Impact factor: 3.169

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  1 in total

1.  Transcriptomic evidence for immaturity of the prefrontal cortex in patients with schizophrenia.

Authors:  Hideo Hagihara; Koji Ohira; Keizo Takao; Tsuyoshi Miyakawa
Journal:  Mol Brain       Date:  2014-05-29       Impact factor: 4.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.